1. Prediction of local and metastatic recurrence in solitary fibrous tumor: Construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database
- Author
-
Salas, Sébastien, Cupissol, Didier, Delcambre, Corinne, Bay, Jacques Olivier, Dubray-Longeras, Pascale, Krengli, Marco, De Bari, Berardino, Villa, Salvador, Kaanders, Johannes Hans A M Hans J.H., Torrente, Sara, Pasquier, David, Resseguier, Noémie, Thariat, Juliette, Myroslav, L., Sole, Claudio C.V., Dincbas, H.F., Habboush, Jacob J.Y., Zilli, Thomas, Dragan, Tatiana, Khanfir, Kaouthar, Ugurluer, Gamze, Cena, Tiziana, Blay, Jean Yves, Duffaud, Florence, Penel, Nicolas, Bertucci, François, Ranchère-Vince, Dominique, Terrier, Philippe, Bonvalot, Sylvie, Macagno, Nicolas, Lemoine, Coralie, Lae, Marick, Coindre, Jean Michél, Le Cesne, Axel Le A., Bouvier, Corinne, Italiano, Antoine, Chevreau, Christine, Rosset, Philippe, Isambert, Nicolas, Soulié, Patrick, Salas, Sébastien, Cupissol, Didier, Delcambre, Corinne, Bay, Jacques Olivier, Dubray-Longeras, Pascale, Krengli, Marco, De Bari, Berardino, Villa, Salvador, Kaanders, Johannes Hans A M Hans J.H., Torrente, Sara, Pasquier, David, Resseguier, Noémie, Thariat, Juliette, Myroslav, L., Sole, Claudio C.V., Dincbas, H.F., Habboush, Jacob J.Y., Zilli, Thomas, Dragan, Tatiana, Khanfir, Kaouthar, Ugurluer, Gamze, Cena, Tiziana, Blay, Jean Yves, Duffaud, Florence, Penel, Nicolas, Bertucci, François, Ranchère-Vince, Dominique, Terrier, Philippe, Bonvalot, Sylvie, Macagno, Nicolas, Lemoine, Coralie, Lae, Marick, Coindre, Jean Michél, Le Cesne, Axel Le A., Bouvier, Corinne, Italiano, Antoine, Chevreau, Christine, Rosset, Philippe, Isambert, Nicolas, and Soulié, Patrick
- Abstract
Background: Solitary fibrous tumors (SFT) are rare unusual ubiquitous soft tissue tumors that are presumed to be of fibroblastic differentiation. At present, the challenge is to establish accurate prognostic factors. Patients and methods: A total of 214 consecutive patients with SFT diagnosed in 24 participating cancer centers were entered into the European database (www.conticabase.org) to perform univariate and multivariate analysis for overall survival (OS), local recurrence incidence (LRI) and metastatic recurrence incidence (MRI) by taking competing risks into account. A prognostic model was constructed for LRI and MRI. Internal and external validations of the prognostic models were carried out. An individual risk calculator was carried out to quantify the risk of both local and metastatic recurrence. Results: We restricted our analysis to 162 patients with local disease. Twenty patients (12.3%) were deceased at the time of analysis and the median OS was not reached. The LRI rates at 10 and 20 years were 19.2% and 38.6%, respectively. The MRI rates at 10 and 20 years were 31.4% and 49.8%, respectively. Multivariate analysis retained age and mitotic count tended to significance for predicting OS. The factors influencing LRI were viscera localization, radiotherapy and age. Mitotic count, tumor localization other than limb and age had independent values for MRI. Three prognostic groups for OS were defined based on the number of unfavorable prognostic factors and calculations were carried out to predict the risk of local and metastatic recurrence for individual patients. Conclusion: LRI and MRI rates increased between 10 and 20 years so relapses were delayed, suggesting that long-term monitoring is useful. This study also shows that different prognostic SFT sub-groups could benefit from different therapeutic strategies and that use of a survival calculator could become standard practice in SFTs to individualize treatment based on the clinical situation., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2017